Circulating tumour DNA for monitoring colorectal cancer—a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection
Abstract Background Cell-free circulating tumour-derived DNA (ctDNA) can be detected by testing for methylated BCAT1 and IKZF1 DNA, which has proven sensitivity for colorectal cancer (CRC). A prospective correlative biomarker study between presence of methylated BCAT1 and IKZF1 in tissue and blood w...
Main Authors: | Erin L. Symonds, Susanne K. Pedersen, David H. Murray, Maher Jedi, Susan E. Byrne, Philippa Rabbitt, Rohan T. Baker, Dawn Bastin, Graeme P. Young |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Clinical Epigenetics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13148-018-0500-5 |
Similar Items
-
Circulating tumour DNA and MRI circumferential resection margin are key prognostic indicators for survival in rectal cancer
by: A. Roy, et al.
Published: (2023-12-01) -
Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1
by: Erin L. Symonds, et al.
Published: (2022-05-01) -
Detection of methylated BCAT1 and IKZF1 after curative‐intent treatment as a prognostic indicator for colorectal cancer recurrence
by: Susanne K. Pedersen, et al.
Published: (2023-01-01) -
Ruscogenin Alleviates Myocardial Ischemia-Induced Ferroptosis through the Activation of BCAT1/BCAT2
by: Fei Fu, et al.
Published: (2022-03-01) -
From Enemy to Ally: Harnessing CPR1 for Soybean Defense Strategies
by: Meenu Singla-Rastogi
Published: (2024-11-01)